Form 4: Lam Research Director Boosts Stake with Share Grant

Lam Research Corp. Director Ita M. Brennan acquired 1,635 shares of common stock at no cost, increasing her beneficial ownership to 5,342 shares.

Summary

• Ita M. Brennan, a Director at Lam Research Corp. (LRCX), acquired 1,635 shares of common stock.
• The transaction occurred on November 7, 2025, and was executed at a price of $0 per share, indicating a grant or compensation.
• Following this acquisition, Ms. Brennan's total beneficial ownership in Lam Research Corp. stands at 5,342 shares.
• The reported amount of beneficially owned securities includes shares subject to unvested restricted stock units.
• The transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan for the purchase or sale of equity securities.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even if through compensation, generally signals alignment of interests with shareholders and confidence in the company's future.

Positives

• The acquisition of shares by a director, even if through compensation, generally signals alignment of interests with shareholders and confidence in the company's future.
• The transaction was executed under a Rule 10b5-1 plan, indicating a pre-planned and structured approach to equity ownership by the director.

Future Outlook

The transaction was executed pursuant to a Rule 10b5-1 pre-arranged trading plan, indicating a structured approach to equity transactions by the director.

Industry Context

This filing reports an individual insider transaction and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders may view the increased director ownership as a positive sign of management's alignment with shareholder interests.

Key Dates

Recommendation

This Form 4 reports a routine equity compensation grant to a director, which is a common practice and does not provide sufficient new information to alter an existing investment thesis for Lam Research Corp. It primarily indicates ongoing director alignment with shareholder interests.

Keywords

Lam Research, LRCX, Insider Transaction, Form 4, Director Ownership, Equity Compensation, Restricted Stock Units, 10b5-1 Plan